This mechanical irritation may be exacerbated by improper injection technique, including injecting too rapidly, using a dull needle, or failing to allow the medication to reach room temperature before administration
Exclusive Pharma Industry 4 min read After WHO nod, Indian Patient Groups urge GLP-1 inclusion in NLEM With the WHO recommending blockbuster GLP-1 therapies such as Semaglutide and Tirzepatide as essential medicines for diabetes, patient advocates in India are urging their inclusion in the National List of Essential Medicines (NLEM) to enable state procurement, free distribution, and wider affordability
How tough the competition is in the GLP-1 market will also depend on the number of players in the first launch wave
For many people, the switch comes down to cost and coverage, not just which medication works better
Create Educational, Legally Safe Content Develop content explaining GLP-1s generally: how they work, what to expect, risks, and alternatives